|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1201 Maryland Avenue SW |
Address2 | Suite 900 |
| City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 6245-12
|
||||||||
|
6. House ID# 325050000
|
||||||||
| TYPE OF REPORT | 8. Year | 2010 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Brent DelMonte, Vice President for Federal Government Relations |
Date | 01/20/2011 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
Cartagena Biosafety Protocol
U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings
Foreign Agricultural Biotechnology Laws and Regulations
International Biotechnology Agreement
EU Biotechnology Bilateral Discussions
China Biotechnology Regulations
Funding for the USDA
S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
USDA/APHIS Agricultural Biotechnology Regulations
Coexistence of Production Systems
Biomass Crop Assistance Program
Funding: H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
Global Food Security Initiative
Funding: S. 3676: Department of State, Foreign Operations and Related Programs Appropriations Act for FY 2011
U.S. Policy on International Science-Based Regulations
U.S. Government Agriculture Research Funding
S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
Genetically Engineered (GE) Animals
Labeling
FDA Approval
S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
Adventitious Presence (Low Level Presence)
U.S. Low Level Presence Policy
European Union Low Level Presence Policy
17. House(s) of Congress and Federal agencies Check if None
U.S. Trade Representative (USTR), Food & Drug Administration (FDA), Agriculture - Dept of (USDA), State - Dept of (DOS), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP),
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Bomer Lauritsen |
|
|
|
David |
Edwards |
|
|
|
Matthew |
OMara |
|
|
|
Bill |
Olson |
|
|
|
Patrick |
Carroll |
|
|
|
Brent |
DelMonte |
|
|
|
Anna |
Weinstein |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
Genetically Engineered (GE) Animals
Labeling
FDA Approval
Genetically Engineered (GE) Animals Cont...
S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Office of Science & Technology Policy (OSTP), U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Bomer Lauritsen |
|
|
|
David |
Edwards |
|
|
|
Bill |
Olson |
|
|
|
Patrick |
Carroll |
|
|
|
Brent |
DelMonte |
|
|
|
Anna |
Weinstein |
|
|
|
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Livestock Cloning/Product Labeling
S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
Funding for USDA (Office of General Counsel , Biotechnology Regulatory Services, Animal Care & Veterinary Services
(APHIS), Trade Activities (Office of the Secretary & Food Safety Inspection Service), Agriculture Research Service,
Biofuels, Foreign Agricultural Service)
S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
Funding for Biofuels
S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
S. 3635: Energy and Water Development and Related Agencies Appropriations Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
Biomass Crop Assistance Program
Rural Energy for America Program
Biomass and Biorefinery Systems R&D Programs
DOE Loan Guarantees and Grants under The Energy Policy Act of 2005 (Implementation and Funding)
Funding for Bio-based Products
S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for
FY 2011
S. 3635: Energy and Water Development and Related Agencies Appropriations Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
Funding for Biorefineries
S. 3635: Energy and Water Development and Related Agencies Appropriations Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
Reverse Auction Loan Program Under Section 942 of the Energy Policy Act of 2005
Drug Importation
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
S.3607: Department of Homeland Security Appropriations Act for FY 2011
S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
Funding for National Institutes of Health
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
Funding for Cures Acceleration Network
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
Funding for Pandemic Influenza Preparedness
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
Funding for Biomedical Advanced Research & Development Authority (BARDA)
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
Funding for Bioterrorism and Emergency Preparedness
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
Funding for Centers for Disease Control and Prevention Vaccine Programs
S.3686: Departs of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
Funding for Strategic National Stockpile
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
Funding for Biotechnology Research and Development Programs at the Agency for International Development
S. 3676: Department of State, Foreign Operations and Related Programs Appropriations act for FY 2011
Funding for the Bureau of Economic, Energy, and Business Affairs (EEB) at the U.S. Department of State
S. 3676: Department of State, Foreign Operations and Related Programs Appropriations act for FY 2011
Generic Drug Patent Settlements
S. 3677: Financial Services and General Government Appropriations Act for FY 2011
Funding for Biodefense Research, Development and Procurement
H.R. 3082: 4th Continuing Appropriations Act for FY 2011
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010
Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Regan-Udall Foundation, Center
for Veterinary Medicine, Scientific Infrastructure)
S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
Funding for Global Food Security Initiative
S. 3676: Department of State, Foreign Operations and Related Programs Appropriations Act for FY 2011
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES,
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Patrick |
Carroll |
|
|
|
Matt |
Carr |
|
|
|
Matthew |
Schumaker |
|
|
|
Phyllis |
Arthur |
|
|
|
Andrew |
Emmett |
|
|
|
Bill |
Olson |
|
|
|
Tom |
DiLenge |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CAW
16. Specific lobbying issues
Climate Change Benefits of Biofuels and Bio-based Products
Biogenic Carbon Emissions Accounting
IP Rights for Environmental Technologies
U.S. Government Position for U.N. Convention on Climate Change Negotiations
17. House(s) of Congress and Federal agencies Check if None
Environmental Protection Agency (EPA), State - Dept of (DOS), U.S. Trade Representative (USTR), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Commerce - Dept of (DOC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matt |
Carr |
|
|
|
Lila |
Feisee |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
IP Rights for Environmental Technologies
U.S. Government Position for U.N. Convention on Climate Change Negotiations
PTO Administrative Reforms
Humanitarian Voucher
Generic Drug Patent Settlements
S. 3677: Financial Services and General Government Appropriations Act for 2011
H.R. 3082: 4th Continuing Appropriations Act for FY 2011
S. 4322: Preserve Access to Affordable Generics Act
Patent Reform
S. 515: The Patent Reform Act of 2009
Genetic Resource Patent Disclosure Requirement
Convention on Biological Diversity
DNA Patenting and Licensing
Genomic Research and Accessibility Act Discussion Draft (Rep. Becerra)
Amicus Matters
Possible Legislation by Rep. Wasserman Schultz
Bayh-Dole Act/Tech Transfer
Commercialization of Federally Funded Research Initiative
Patent Presumption of Validity
Amicus Matters
17. House(s) of Congress and Federal agencies Check if None
State - Dept of (DOS), U.S. Trade Representative (USTR), Patent & Trademark Office (PTO), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Commerce - Dept of (DOC), Office of Science & Technology Policy (OSTP), White House Office, Health & Human Services - Dept of (HHS), Justice - Dept of (DOJ), Intl Trade Administration (ITA), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Agriculture - Dept of (USDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lila |
Feisee |
|
|
|
Hans |
Sauer |
|
|
|
Matthew |
Schumaker |
|
|
|
Anna |
Weinstein |
|
|
|
Melissa |
Bowie |
|
|
|
Cartier |
Esham |
|
|
|
Tom |
DiLenge |
|
|
|
Patrick |
Carroll |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
USDA/APHIS Agricultural Biotechnology Regulations
Coexistence of Production Systems
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
Genetically Engineered (GE) Animals
Labeling
FDA Approval
S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
Generic Drug Patent Settlements
S. 3677: Financial Services and General Government Appropriations Act for FY 2011
H.R. 3082: 4th Continuing Appropriations Act for FY 2011
S. 4322: Preserve Access to Affordable Generics Act
Drug Safety and Review
FDA Globalization Act (Discussion Draft)
Prescription Drug User Fee Act (PDUFA) Reauthorization
Drug Importation
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
S.3607: Department of Homeland Security Appropriations Act for FY 2011
S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Regan-Udall Foundation, Center for Veterinary
Medicine, Scientific Infrastructure)
S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
17. House(s) of Congress and Federal agencies Check if None
Agriculture - Dept of (USDA), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), U.S. Trade Representative (USTR), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Bomer Lauritsen |
|
|
|
Bill |
Olson |
|
|
|
David |
Edwards |
|
|
|
Andrew |
Emmett |
|
|
|
Matthew |
Schumaker |
|
|
|
Anna |
Weinstein |
|
|
|
Brent |
DelMonte |
|
|
|
Tom |
DiLenge |
|
|
|
Sara |
Radcliffe |
|
|
|
Patrick |
Carroll |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENG
16. Specific lobbying issues
Climate Change Benefits of Biofuels and Bio-based Products
Biogenic Carbon Emissions Accounting
Renewable Fuels Standard
Implementation of Energy Independence and Security Act of 2007
Biofuels
Biofuels Production Tax Credit Modification for Algae-based Biofuels
H.R. 4168: Algae-based Renewable Fuel Promotion Act of 2010
Biofuels Production Tax Credit Extension:
H.R. 5142: Grow Renewable Energy Economy Now-Jumpstart Other Biofuels Act of 2010
Next Generation Incentives: Farm Bill Reauthorization
Domestic Manufacturing and Energy Jobs Act of 2010 (Discussion Draft)
DOE Loan Guarantees and Grants under The Energy Policy Act of 2005 (Implementation and Funding)
H.R. 6564: Oil Independence for a Stronger America Act of 2010
H.R. 6554: Domestic Fuel for Enhancing National Security Act of 2010
S. 3807: American Security and Freedom Fuels Act of 2010
Funding:
S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
S. 3635: Energy and Water Development and Related Agencies Appropriations Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
Biomass Crop Assistance Program
Rural Energy for America Program
Biomass and Biorefinery Systems R&D Programs
Bio-based Products
Tax Credit
Expansion of DOE and USDA Loan Guarantee Programs
Next Generation Incentives: Farm Bill Reauthorization
USDA BioPreferred Program
Funding:
S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
S. 3635: Energy and Water Development and Related Agencies Appropriations Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
Biorefineries
Funding for Reverse Auction Loan Program under Section 942 of the Energy Policy Act of 2005
S. 3635: Energy and Water Development and Related Agencies Appropriations Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
17. House(s) of Congress and Federal agencies Check if None
Environmental Protection Agency (EPA), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Energy - Dept of, Agriculture - Dept of (USDA), Defense - Dept of (DOD), Navy - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matt |
Carr |
|
|
|
Bill |
Olson |
|
|
|
Patrick |
Carroll |
|
|
|
Paul |
Poteet |
|
|
|
Brent DelMonte |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
Global Food Security Initiative
Funding: S.3676: Department of State, Foreign Operations and Related Programs Appropriations Act for FY 2011
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
Genetically Engineered (GE) Animals
Labeling
FDA Approval
S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), U.S. Trade Representative (USTR), Office of Science & Technology Policy (OSTP)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Bomer Lauritsen |
|
|
|
Bill |
Olson |
|
|
|
David |
Edwards |
|
|
|
Patrick |
Carroll |
|
|
|
Brent |
DelMonte |
|
|
|
Anna |
Weinstein |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FUE
16. Specific lobbying issues
Climate Change Benefits of Biofuels and Bio-based Products
Biogenic Carbon Emissions Accounting
Renewable Fuels Standard
Implementation of Energy Independence and Security Act of 2007
Biofuels
Biofuels Production Tax Credit Modification for Algae-based Biofuels
H.R. 4168: Algae-based Renewable Fuel Promotion Act of 2010
Biofuels Production Tax Credit Extension:
H.R. 5142: Grow Renewable Energy Economy Now-Jumpstart Other Biofuels Act of 2010
Next Generation Incentives: Farm Bill Reauthorization
Domestic Manufacturing and Energy Jobs Act of 2010 (Discussion Draft)
DOE Loan Guarantees and Grants under The Energy Policy Act of 2005 (Implementation and Funding)
H.R. 6564: Oil Independence for a Stronger America Act of 2010
H.R. 6554: Domestic Fuel for Enhancing National Security Act of 2010
S. 3807: American Security and Freedom Fuels Act of 2010
Funding:
S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
S. 3635: Energy and Water Development and Related Agencies Appropriations Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
Biomass Crop Assistance Program
Rural Energy for America Program
Biomass and Biorefinery Systems R&D Programs
Bio-based Products
Tax Credit
Expansion of DOE and USDA Loan Guarantee Programs
Next Generation Incentives: Farm Bill Reauthorization
USDA BioPreferred Program
Funding:
S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
S. 3635: Energy and Water Development and Related Agencies Appropriations Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
Biorefineries
Funding for Reverse Auction Loan Program under Section 942 of the Energy Policy Act of 2005
S. 3635: Energy and Water Development and Related Agencies Appropriations Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
17. House(s) of Congress and Federal agencies Check if None
Environmental Protection Agency (EPA), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Energy - Dept of, Agriculture - Dept of (USDA), Defense - Dept of (DOD), Navy - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matt |
Carr |
|
|
|
Bill |
Olson |
|
|
|
Patrick |
Carroll |
|
|
|
Paul |
Poteet |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Pharmaceutical Industry Annual Fee
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Treasury and IRS Regulations Implementing the Law
Biosimilars
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Comparative Effectiveness Program Initiatives
Nomination of Board Members for the Patient-Centered Outcomes Research Institute
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Vaccine Access/Financing
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Expansion of 340B Drug Pricing Program
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
H.R. 4994: Taxpayer Assistance Act of 2010
H.R. 4213: American Jobs and Closing Tax Loopholes Act of 2010
Funding for Centers for Disease Control and Prevention Vaccine Programs
S.3686: Departs of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
Funding for Strategic National Stockpile
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Regan-Udall Foundation, Center
for Veterinary Medicine, Scientific Infrastructure)
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
Drug Importation
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
S.3607: Department of Homeland Security Appropriations Act for FY 2011
S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
Funding for National Institutes of Health
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
Cures Acceleration Network
Funding:
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
Funding for Pandemic Influenza Preparedness
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
Funding for Biomedical Advanced Research & Development Authority (BARDA)
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
Funding for Bioterrorism and Emergency Preparedness
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
Biodefense Research, Development and Procurement
HHS Countermeasures Review
Funding:
H.R. 3082: 4th Continuing Appropriations Act for FY 2011
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010
Stem Cell Research
Federal Funding of Embryonic Stem Cell Research
Average Manufacturer Price Calculations
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010
H.R. 4213: American Jobs and Closing Tax Loopholes Act of 2010
Diagnostics and Personalized Medicine Regulation and Oversight
Draft Legislation
Therapeutic Discovery Project Tax Credit
Extension
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Drug Safety and Review
FDA Globalization Act (Discussion Draft)
Prescription Drug User Fee Act (PDUFA) Reauthorization
Generic Drug Patent Settlements
S. 3677: Financial Services and General Government Appropriations Act for FY 2011
H.R. 3082: 4th Continuing Appropriations Act for FY 2011
S. 4322: Preserve Access to Affordable Generics Act
Independent Payment Advisory Board
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
17. House(s) of Congress and Federal agencies Check if None
Internal Revenue Service (IRS), Treasury - Dept of, Natl Security Council (NSC), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health Resources & Services Administration (HRSA), White House Office, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Food & Drug Administration (FDA), Government Accountability Office (GAO), Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Shelly |
Mui-Lipnik |
|
|
|
Paul |
Poteet |
|
|
|
Lauren |
Neff |
|
|
|
Andrew |
Emmett |
|
|
|
Matthew |
Schumaker |
|
|
|
Jeanne |
Haggerty |
|
|
|
Sara |
Radcliffe |
|
|
|
Cartier |
Esham |
|
|
|
Anna |
Weinstein |
|
|
|
Melissa |
Bowie |
|
|
|
Sandra |
Dennis |
|
|
|
Alan |
Eisenberg |
|
|
|
Tooshar |
Swain |
|
|
|
Patrick |
Carroll |
|
|
|
Phyllis |
Arthur |
|
|
|
Tom |
DiLenge |
|
|
|
Brent |
DelMonte |
|
|
|
. |
. |
|
|
|
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOM
16. Specific lobbying issues
Funding for Strategic National Stockpile
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
Biodefense Research, Development and Procurement
HHS Countermeasures Review
Funding:
H.R. 3082: 4th Continuing Appropriations Act for FY 2011
H.R. 4899: Emergency Supplemental Appropriations Act for 2010
Funding for Pandemic Influenza Preparedness
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies
Appropriations Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
Funding for Bioterrorism and Emergency Preparedness
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
Funding for Biomedical Advanced Research & Development Authority (BARDA)
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
17. House(s) of Congress and Federal agencies Check if None
Natl Security Council (NSC), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Defense - Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), Natl Institutes of Health (NIH), Office of the Secretary of Defense
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Melissa |
Bowie |
|
|
|
Anna |
Weinstein |
|
|
|
Phyllis |
Arthur |
|
|
|
Matthew |
Schumaker |
|
|
|
Patrick |
Carroll |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Comparative Effectiveness Program Initiatives
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Nomination of Board Members for the Patient-Centered Outcomes Research Institute
Funding for Biomedical Advanced Research & Development Authority (BARDA)
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
Funding for Bioterrorism and Emergency Preparedness
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
Funding for Pandemic Influenza Preparedness
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
Funding for National Institutes of Health
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
Cures Acceleration Network
Funding:
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
H.R. 3082/HJ RES. 105/HJ RES. 101/S. Amendment to H. 3081: Continuing Appropriations Acts for FY 2011
Stem Cell Research
Federal Funding of Embryonic Stem Cell Research
Biodefense Research, Development and Procurement
HHS Countermeasures Review
Funding:
H.R. 3082: 4th Continuing Appropriations Act for FY 2011
H.R. 4899: Emergency Supplemental Appropriations Act for 2010
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Centers For Medicare and Medicaid Services (CMS), Natl Security Council (NSC), Defense - Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), Office of the Secretary of Defense, Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Schumaker |
|
|
|
Jeanne |
Haggerty |
|
|
|
Sara |
Radcliffe |
|
|
|
Lauren |
Neff |
|
|
|
Anna |
Weinstein |
|
|
|
Melissa |
Bowie |
|
|
|
Phyllis |
Arthur |
|
|
|
Patrick |
Carroll |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Independent Payment Advisory Board
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Average Manufacturer Price Calculations
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010
H.R. 4213: American Jobs and Closing Tax Loopholes Act of 2010
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Schumaker |
|
|
|
Melissa |
Bowie |
|
|
|
Jeanne |
Haggerty |
|
|
|
Anna |
Weinstein |
|
|
|
Brent |
DelMonte |
|
|
|
Patrick |
Carroll |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
Stem Cell Research
Federal Funding of Embryonic Stem Cell Research
Small Business Innovation and Research (SBIR) Program Reauthorization
H.R. 2965/S.1233: Enhancing Small Business Research and Innovation Act of 2009
S. 4053: SBIR/STTR Reauthorization Act of 2010
Research & Development Tax Credit Extension
H.R. 4853: Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Natl Economic Council (NEC), Natl Institutes of Health (NIH), Small Business Adminstration (SBA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tom |
DiLenge |
|
|
|
Cartier |
Esham |
|
|
|
Paul |
Poteet |
|
|
|
Alan |
Eisenberg |
|
|
|
Sara |
Racliffe |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SMB
16. Specific lobbying issues
Small Business Innovation and Research (SBIR) Program Reauthorization
H.R. 2965/S.1233: Enhancing Small Business Research and Innovation Act of 2009
S. 4053: SBIR/STTR Reauthorization Act of 2010
Sarbanes Oxley Section 404 (b) Exemption
H.R. 4173: Wall Street Reform and Consumer Protection Act of 2009
Therapeutic Discovery Project Tax Credit
Extension
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Internal Revenue Service (IRS), Treasury - Dept of, Natl Institutes of Health (NIH), Natl Economic Council (NEC), Securities & Exchange Commission (SEC), Small Business Adminstration (SBA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cartier |
Esham |
|
|
|
Paul |
Poteet |
|
|
|
Alan |
Eisenberg |
|
|
|
Shelly |
Mui-Lipnik |
|
|
|
Tooshar |
Swain |
|
|
|
Brent |
DelMonte |
|
|
|
Tom |
DiLenge |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Biofuels Production Tax Credit Extension
H.R. 5142: Grow Renewable Energy Economy Now-Jumpstart Other Biofuels Act of 2010
Biofuels Production Tax Credit Modification for Algae-based Biofuels
H.R. 4168: Algae-based Renewable Fuel Promotion Act of 2010
H.R. 5142: Grow Renewable Energy Economy Now-Jumpstart Other Biofuels Act of 2010
Bio-based Products
Tax Credit
Therapeutic Discovery Project Tax Credit
Extension
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Pharmaceutical Industry Annual Fee
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Treasury and IRS Regulations Implementing the Law
Research & Development Tax Credit Extension
H.R. 4853: Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Internal Revenue Service (IRS), Treasury - Dept of, Natl Institutes of Health (NIH), Agriculture - Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Defense - Dept of (DOD), Energy - Dept of, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Bill |
Olson |
|
|
|
Shelly |
Mui-Lipnik |
|
|
|
Paul |
Poteet |
|
|
|
Lauren |
Neff |
|
|
|
Cartier |
Esham |
|
|
|
Matt |
Carr |
|
|
|
Tooshar |
Swain |
|
|
|
Alan |
Eisenberg |
|
|
|
Anna |
Weinstein |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
Cartagena Biosafety Protocol
U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
U.S. Policy on International Science-Based Regulations
Drug Importation
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
S.3607: Department of Homeland Security Appropriations Act for FY 2011
S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
Foreign Agricultural Biotechnology Laws and Regulations
International Biotechnology Agreement
EU Biotechnology Bilateral Discussions
China Biotechnology Regulations
Genetic Resource Patent Disclosure Requirement
Convention on Biological Diversity
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, U.S. Trade Representative (USTR), Agriculture - Dept of (USDA), State - Dept of (DOS), Commerce - Dept of (DOC), Patent & Trademark Office (PTO), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Bomer Lauritsen |
|
|
|
David |
Edwards |
|
|
|
Matthew |
OMara |
|
|
|
Bill |
Olson |
|
|
|
Patrick |
Carroll |
|
|
|
Lila |
Feisee |
|
|
|
Tom |
DiLenge |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Comparative Effectiveness Program Initiatives
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Nomination of Board Members for the Patient-Centered Outcomes Research Institute
Drug Safety and Review
FDA Globalization Act (Discussion Draft)
Prescription Drug User Fee Act (PDUFA) Reauthorization
Drug Importation
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
S.3607: Department of Homeland Security Appropriations Act for FY 2011
S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Government Accountability Office (GAO)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lauren |
Neff |
|
|
|
Matthew |
Schumaker |
|
|
|
Jeanne |
Haggerty |
|
|
|
Sara |
Radcliffe |
|
|
|
Andrew |
Emmett |
|
|
|
Patrick |
Carroll |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address | |
||||||
| City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
| City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
5 |
|
||||||
| 2 |
|
6 |
|
||||||
| 3 |
|
7 |
|
||||||
| 4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
TOR |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address: BIO maintains a list of all of its members on its website at http://bio.org/membership/index.asp
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 3 | 5 |
| 2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 5 | 9 |
| 2 | 6 | 10 |
| 3 | 7 | 11 |
| 4 | 8 | 12 |